Scandinavian Biolab (SBL), the Danish innovator in the hair care industry, has announced the completion of a €4 million investment round led by Aurea Group, a key milestone in the company’s growth journey. Aurea will join existing investor Blazer Capital on SBL’s board of directors.
Founded in 2020, Scandinavian Biolab has established itself as a leader in science-backed, non-invasive prevention products targeting early-stage hair loss. The company’s flagship product, Bio-Pilixin® Activation Serum, has revolutionized the market and is being clinically tested for its positive effects.
Scandinavian Biolabs was initially launched as a direct-to-consumer (DTC) brand and quickly built a loyal customer base through its online platform. Building on this success, the brand expanded to retail stores and various pharmacies in multiple regions.
Anders Reckendorff, CEO and co-founder of Scandinavian Biolabs, said: “We have built a strong foundation with innovative products and proven that if we can deliver value and results to our customers, we can also have a strong business. Through our experience and know-how, we will continue to grow our company. We are pleased to have new investors join us who will contribute to our efforts.”
With over 140,000 customers supported to date and a Trustpilot score of 4.5 out of 5, Scandinavian Biolabs is committed to being the recommended solution for reliable, tested, honest hair care products that are right for you. It’s progressing rapidly. SevenVentures (part of the Pro. SiebenSat.1 group) supports its expansion in Germany through strategic television collaborations.
With a €4 million cash injection from Aurea, Scandinavian Biolab will pursue its ambitious growth plans more aggressively, establishing a leadership position in the UK, Germany and the Nordic countries, while also entering the US market. It will be possible to expand your business through online services. Expand strategic retail such as pharmacies.
Aurea Fund commented: “Aurea is delighted to have been selected as a preferred investor in Scandinavian Biolabs, recognizing the experience and operational value we bring in addition to the growth capital. We believe in the truly differentiated and effective product we have developed and we are confident that together we can grow this into a significant international brand.”
– Advertisement –
Source link
